Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 9.16%
March 31, 2026 -4.28%
December 31, 2025 -9.15%
September 30, 2025 4.04%
June 30, 2025 11.16%
March 31, 2025 5.40%
December 31, 2024 -22.50%
September 30, 2024 16.64%
June 30, 2024 -176.9%
March 31, 2024 -354.0%
December 31, 2023 -2.07K%
September 30, 2023 -4.69K%
June 30, 2023 -1.45K%
March 31, 2023 -1.51K%
December 31, 2022 -1.33K%
September 30, 2022 -979.8%
June 30, 2022 -1.27K%
March 31, 2022 -2.38K%
December 31, 2021 -253.7%
September 30, 2021 -1.36K%
June 30, 2021 -1.20K%
March 31, 2021 -1.74K%
December 31, 2020 -1.39K%
September 30, 2020 -1.07K%
June 30, 2020 -1.13K%
Date Value
March 31, 2020 -2.67K%
December 31, 2019
September 30, 2019 -1.98K%
June 30, 2019 -1.45K%
March 31, 2019 -2.92K%
December 31, 2018 -1.06K%
September 30, 2018 -1.08K%
June 30, 2018 -776.0%
March 31, 2018
December 31, 2017 -2.73K%
September 30, 2017 -1.84K%
June 30, 2017 -332.7%
March 31, 2017 -1.53K%
December 31, 2016 -1.26K%
September 30, 2016 -231.0%
June 30, 2016 -1.30K%
March 31, 2016 -490.0%
December 31, 2015 -1.16K%
September 30, 2015 -607.0%
June 30, 2015 -793.8%
March 31, 2015 -785.6%
December 31, 2014 -1.01K%
September 30, 2014 -2.10K%
June 30, 2014 -1.83K%
March 31, 2014 -1.70K%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
AngioDynamics, Inc. -8.77%
Alphatec Holdings, Inc. -12.07%
AtriCure, Inc. 5.83%
Baxter International, Inc. 4.56%